Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement

2020 ◽  
Vol 39 (8) ◽  
pp. 2441-2448
Author(s):  
Misako Higashida-Konishi ◽  
Keisuke Izumi ◽  
Masako Tsukamoto ◽  
Hiroaki Ohya ◽  
Nozomi Takasugi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Central Nervous System ◽  
Cerebrospinal Fluid ◽  
Nervous System ◽  
Central Nervous System Involvement ◽  
System Involvement ◽  
Cyclic Citrullinated Peptide ◽  
Peptide Antibody ◽  
Citrullinated Peptide

An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis

2008 ◽  
Vol 29 (11) ◽  
pp. 1349-1353 ◽  
Author(s):  
Aslı Kurne ◽  
Rana Karabudak ◽  
Ömer Karadag ◽  
Gül Yalcin-Cakmakli ◽  
Kader Karli-Oguz ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Central Nervous System ◽  
Nervous System ◽  
Central Nervous System Involvement ◽  
Cerebral Vasculitis ◽  
System Involvement

scholarly journals Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib

2017 ◽  
Vol 4 (1) ◽  
Author(s):  
Julia A. Messina ◽  
Eileen K. Maziarz ◽  
Andrej Spec ◽  
Dimitrios P. Kontoyiannis ◽  
John R. Perfect
Keyword(s):  
Central Nervous System ◽  
Cerebrospinal Fluid ◽  
Nervous System ◽  
Central Nervous System Involvement ◽  
Potential Complication ◽  
System Involvement ◽  
Lymphoid Malignancies ◽  
Brain Involvement

Abstract We report 2 cases of disseminated cryptococcosis with central nervous system involvement in patients with chronic lymphoid malignancies occurring within 1 month of starting on ibrutinib. Characteristically, in both cases, no inflammation was seen in the cerebrospinal fluid. Central nervous system mycoses should be considered as a potential complication of ibrutinib.

Sign in / Sign up

Export Citation Format

Share Document